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Pemphigus Ig G induces acantholys is in skin organ culture 
w itho ut the involvement of complem ent. Urokinase-type 
plasm in ogen activator, a proteoly ti c enzyme, has been im-
plica ted in the development of acantho lysis. To tes t this 
hy pothes is, we prepared a rabbit anti-urokinase antibo d y, 
which inhibited the plasminogen activa tor activit y in nor-
m al human epidermis and in cultured keratinocytes . When 
added to skin organ cultures alo ng with pemphig us IgG, 
anti-uro kinase IgG completely prevented the development 
of acanthol ys is. N orm al o r preimmune rabbit Ig G had no 
Pemphig us is a potentiall y fa tal autoimmune disease characterized cl ini ca ll y by seve re blisterin g and erosion of th e skin and mu cous membranes [1]. Histologic examination of pemphigus lesions revea ls intraepider-mal dyshesion and rounded cells that are detached w ithin 
the epi th elium ; this distinctive pattern is termed acantho lys is . 
There are two maj o r types of pemphig us, as distin g uished by 
clini ca l and hi stologic findin gs, i.e. , pemphigus vul garis and pem-
phigus fo liaceo us. [n th e vul ga ris type of pemphi gus, the intra-
epIdermal cleft is o bserved deep in the epidermis, immediately 
above the basa l layer. By contras t, pemphi gus fo liaceous lesions 
are seen hi gher in the epidermis in th e mo re differentiated layers. 
[n bo th pemphigus fo li aceo us and vul ga ris, autoa ntib odies to one 
or mo re epithelial cell surface molecules are present in the serum 
and epithelium. 
T he pathogeni city of these pemphigus autoan tibod ies has been 
demonstrated in several ways: (a) Antibod y titers generall y co r-
relate with disease ac tivity (rev iewed in [2]) ; (b) Aca nth olysis is 
induced in neonatal mice by pass ive transfer of pemphi gus IgG 
[3]; (c) Aca ntho lysis is induced in orga n culture explallts of normal 
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PAc plasminogen acti vato r 
effect on pemphigus IgG-induced acantho lysis. Pl as min-
ogen activato r converts the zy mogen plasminogen to its 
acti ve form plasmin, a broad specificity serine proteinase. 
When high concentrations of plasminogen alone were added 
to skin organ culture, acantholysis of the pemphigus fo l-
iaceo us type was induced. Anti-urokinase antibod y also 
inhibited plasminogen-induced acan th olys is. These results 
strongly support a pi vo tal ro le for plasmi nogen acti vator 
in the development of acanthol ys is. ) In vest D erll1ato! 89: 
474-477, 1987 
skin incubated w ith pemphi gus [gG in the absence of complement 
[4,5]. Thus, the disease- specific histo log ical change, acanth olYS IS , 
is caused by anti-cell surface autoantibodies . 
[t has been pro posed [6] that binding of pemphigus autoanti-
bodies to the epiderm al cell surface induces acanth olyti c changes 
through acti vat ion o f a se rin e pro teinase ca lled plasmin ogen ac-
tivator (PA). One line of ev idence in suppo rt o f thi s hypo thesis 
is the fi ndin g th at pemphig us autoant ibodies selecti vely enhance 
plas minogen activa to r levels in the medi a and lysa tes of prim ary 
human keratin ocyte cultures [6]. [n add ition , inhibi tors of serine 
pro teinases are able to prevent the develo pment of pemphi gus 
IgG-indu ced acanthol ysis in o rga n culture [6,7]. 
Plasminogen ac ti vators are very specific proteinases th at con-
vert the zy mogen pl as minogen into its active form, plasmin. 
Althou gh th e thro mbolyti c ro le of pl as minogen ac ti vato r and 
plasmin is th e one most extensively studied , mu ch recent evidence 
suggests that these enzy mes m ay also be very impo rtanr in a wide 
va ri ety o f loca lized ex tracellular pro teo lytic events such as tissue 
remodeling, cell mig ration and tumor cell in vasio n [S,9·1. There 
are two non-cross-reacti ve fam ilies of plasm inogen ac ti va to r, re-
ferred to as urokinase- type and ti ss ue-type, w hich appea r to have 
separate funct ions [S,9]. 
We hypothesize th at binding of pemphi g us autoanribodies leads 
to an en hanced level of urokinase- type plasminogen acti va tor in 
affec ted epithelium ; the plasminogen ac ti vator may generate lo-
call y high concentrations of plasmin , w hich in turn cleaves one 
or more cell-cell adhesio n molecules and hence produ ces acan-
th olys is [1 0]. 
[n the present stud y we have furth er tes ted thi s hypo th es is using 
skin explant cultures . We have shown that an anti-uro kin ase 
antibod y, whi ch specifi ca ll y blocks u rokinase-type plas min ogen 
acti vator act ivit y, inhibits the aca nthol ysis induced in skin organ 
culture by pemphigus foli aceous o r vul ga ris [gG. [n addition , we 
have found that pl as min ogen alone at high concentrations can 
induce aca ntho lysis in organ culture, indistin guishable fro m that 
seen after incubatio n w ith pemphigus fo liaceous [gG. These ob-
servations support the concept th at an increased ac ti vity of uro-
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kinase-type plasmin ogen activator in loca li zed areas o f th e epi-
dennis medi ates acantho lysis. 
MATERIALS AND METH ODS 
Specimens Normal ad ult breast and face sk in and neonata l 
fo reskin we re obtained from routin e surgica l proced ures . 
Extraction of Plasminogen Activator From Skin Specimens 
~fte r removal of fatty ti ss ue, the remainin g portion of each spec-
Imen was treated for 60 s at 56°C, to all ow separati on of the 
epIdermis from the dermis. The epidermis was ho mogeni zed in 
the co ld in a Dounce ho mogeni zer prior to two-step extract io n 
[ 11 , 12]. Extraction was first ca rried out in O.Ol M sodium phos-
phate pH 7.0 (l ow salt buffer) for 60- 90 min w ith gentl e rotatio n 
at 4°C. The ep iderm al fragments were spun down in an Eppen-
dorf centrifu ge for 5 min at 6800 X g and then was hed once in 
low sa lt buffer . The low salt ex tract has been shown to contain 
one Or 1110re inhibi to rs (M o ri oka, unpublished o bse rva ti ons) of 
p las minogen act iva to r and has litt le «5%) of the to tal PA activ-
Ity. To ex trac t PA , 2M KSC N plus 0. 1 % Triton [1 2] was added 
to the epiderm al pellet; ·ex tractio n was ca rried o ut at 4°C w ith 
gentle rotation for 60- 90 min . After cen trifu gation, th e super-
natant was co ll ected and dial yzed agai nst O. l M Tri s, 111l M EDT A, 
p H 8. 1. 
Plasminogen Activator Assay Plas minogen ac ti vato r acti vity 
was assayed w ith 1251-fibrin-coa ted 24-well tiss ue culture plates 
[13] as prev io usly described [6]. Plasm inogen-dependent enzy me 
activity was stand ardi zed to milli Plo ug units per ml (mPU/ ml) 
using a human urokinase reference standard (Leo Pharmaceutical 
Ind ustries, Ballerup, Denmark) in th e presence of2. 5 J.Lg per assay 
well of human plas minogen [1 4]. All assays were performed in 
the linea r range o f standard urokin ase acti vities . 
Preparation of Antibody to Plasminogen Activator A 
polyclona l antibody aga in st human urin ary plasminogen ac ti vator 
(urokinase) was prepared by immunizi ng rabb its w ith purified 
uroki nase consis tin g of both 54,000 and 32,000 dalton forms [1 5J. 
Anti-urokinase IgG and no rmal rabbit IgG were purifi ed using 
affinity co lmumn chrom atog raph y on Iys ine-Sepharose to re-
move plasminogen and then on protein A- Sepharose , as previ-
ously described [15]. 
Preparation of Pemphigus IgG Plasminogen-free pemphigus 
IgG from pemphi gus vulgaris and foliaceous patients was pre-
pa red by seq uential column chro matog raph y on Iys ine-Sepharose 
fo llowed by protein A-Sepharose, as previously described [6, 15]. 
Skin Organ Culture Skin o rgan cu lture experim ents were per-
formed usin g the lens paper raft technique [7]. After removal of 
fatty tiss ue, neonatal foreskin was cut into 4 X 4 mm pieces. Skin 
pieces were pl aced dermis side down on paraffi n-rimm ed 20 x 
20 I11Ill lens paper rafts and fl oa ted o n Dulbecco 's modified Eagle 
med ium plus 15mM HEPES in th e absence of serum 
(DME/ HEPES). Pemphi gus IgG and anti- urokinase IgG o r con-
tral rabbit IgG (O. lm g/mI) were included in the media . In some 
experiments plasminogen (0.26 mg/ ml) was added to o rgan cul-
tures in the presence of anti-u rokin ase o r control rabbit IgG. After 
24-48 h in culture, the skin explants were harves ted and processed 
for histologica l exa min ation w ith hematoxylin and eosin stainin g . 
RESULTS 
Characterization of Epidermal PA We previously showed 
that anti-uro kin ase IgG totally inhibited purified urin ary uroki-
nase, as well as PA activity produced by human epiderm al cell s 
in culture [1 5J. In contras t, anti-urokinase IgG had no effect on 
human tiss ue-type PA acti vity [15). 
To determ ine the type of PA present in normal human epi-
dermis, PA was ex trac ted fro m sepa rated epidermis by incubation 
in 2M KSCN plus 0. 1 % Triton X-I 00. As shown in Fig 1, most 
of th e PA activity ex tracted from either ad ult or neonatal epi-
dermis was inhibited by anti-urokinase IgG . Thus, bo th kerat-
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Figure 1. Inhibition of urokinase standard and cp idermal I'A by 
anti-urokinasc IgG. KSCN /Triton ex tracts ofl1col13 tal foreskil1 epidermis 
(x) o r adult fe m ale breas t ep idermis (,q llares) or standard uro kil1 :1se (rirc/c.i) 
were preincubated at roo m tempera ture fo r 30 min with in d icated con-
centrations ofa mi-uro kil1ase IgG d iluted in 0. 1 M T ris, pH S. I plus 0.25% 
gelatil1 and O. I % Triton X-I OO. Control tubes were in cubated with 20 
o r SO JLg/ ml of norma l rabbit IgG . Duplica te aliquors of each rube wcre 
added to '~5 1-fibrin piate we lls for assay. Activit y in comrol tubes was 20 
mPU / ml for standa rd urokinase, 25 IllPU/ ml for foreskin ep ider m al ex-
tract, and 150 mPU/ ml for breast epiderm al ex tract. The cur ve for s tan-
dard urok inase is a compositc with standard deviations o f 4 separate 
experiments with 3 IgG preparations. 
inocy tes in culture as we ll as freshly isolated epidermi s co ntained 
primari ly uro kinase- type PA act ivity. 
Effect of Anti-urokinase IgG on Acantholysis Induced by 
Pemphigus Antibody As previousl y shown [7). aca nth olys is 
is indu ced in ski n exp lants by pemphigus IgG after 12-48 h in 
culture (Fi g 2C, D). When sk in exp lants were cultured w ith both 
pemphigus IgG and anti-urokinase antibody, th e inducti on o f 
acanthol ys is by pemphig us IgG was completd y blocked (Fig 2A, 
B). Contro l rabb it IgG did not interfere wi th th e induction of 
acanth o lys is (Fig 2C, D). As anti-urokinase IgG blocked the ac-
tivity of human epidermal plasminogen activator, th ese data 
st ro ng ly sugges ted th at pemphi g us IgG-indu ced aca nth o lys is was 
mediated by uroki nase-type pl asm inogen activato r. 
Plasminogen-Induced Acantholysis Previous wo rk has dem-
onstrated th at rhe add itio n of plasminogen to the culture medium 
along with pemphigus IgG caused intensified aca ntholytic changes 
and shortened the tim e before onsct, compa red to the effects of 
pemphigus IgG alone [6 ]. We at tempted to induce pemphigus-
like aca nth o lys is in the absence of pemphi g us IgG, by adding 
hig h levels of plas min ogen alo ne to sk in o rga n cultures. As shown 
in Fig 3B, plas min ogen at 0.26 mg/ ml induced pemphigus fol-
iaceous-l ike aca ntho lysis in normal skin ex plants after 48 h in 
culture. The plas minogen-indu ced acantho lysis was b locked by 
anti-uroki nase IgG (Fig 3A). Addition of purified human urin ary 
urokin2.se alone (2500 PU / ml) did not ca use any signifi cant hi s-
to logic changes in ex plants after 48 h in culture. 
D ISCUSSION 
The o rgan cu lture expe rim ents presented here further support the 
involvement of urokinase-type plasminogen activa to r in pem-
phigus IgG-induced acanth o lys is. Anti-urok inase antibody is a 
specific inhibito r of urokin asc-type plas min ogen activa tor and has 
no effect on tissue-type plasminogen activa to r. By specifi ca ll y 
blocking uroki nase-type plas min ogen acti vato r acti vity w ith this 
antibody, we blocked th e aca nth olysis norma ll y induced by pem-
phigus vul garis or fo liaceous IgG. These findings are cons istent 
w ith ea rlier experiments demonstrating that inhibitors of se rin e 
proteinases blocked pemphig us IgG-induced aca nth olys is [6,7]. 
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Figure 2. Inhibitio n of pcmphigus IgG-induced acantho lys is by anti-urokinase IgG. Explants o f no rmal human skin wc re incubatcd wi th pcmphigus 
vu l!,';a ris IgG at 4.0 m g/ ml (A,C) or pemphigus folia ceous IgG at 4.4 m g/ l11l (B,O ). Rabbit anti-hum an urokinasc IgG (A ,I3) o r nonimlllunc control 
raob it I!,';G (C,O) was also present at 0.1 Illg/ml. C ultures were incubated fo r 48 h at 37°C , after w hich they were processed for ro utin e hi sto logiC 
examination using hem atoxy lin and eos in stains. Slides we re photographed usin g a Zeiss microscope (250 x). N o nimmunc rabbit IgG did no t alter 
the abi lity of pemphig us IgG to induce vulga ri s (C) or fo li aceo us (0 ) type acantho lys is. Anti-urokinase IgG prevcnted the formation of aca ntholysIs 
by either type o f pemphi gus IgG (A ,B) however . 
They more conclusi vely implica te uro kinase-type pl as minogen 
activator in acantholysis, however, beca use of th e specificity of 
the anti-urokinase antibod y . 
Addition of plasminogen intensifies the pemphigus IgG-induced 
acantholytic chan ges [61. but it is not absolutely essential for the 
indu ction of acantholysis [6,1 8]. Pl as min ogen is present in epi-
dermis [1 9], and this endogenous store is presum ab ly activated 
in organ cultures incubated with pemphi gus IgG. 
It is of interes t that hi gh concentrations o f plas min ogen alone 
are able to indu ce foliaceou s-like acanthol ys is in o rgan cultures 
of norm al skin. Normal epiderm is has easi ly meas urable levels 
of endogeno us plasminogen activator, w hi ch probab ly convert 
some of th e exogeno us pl as minogen to plas min in loca lized areas. 
The loca lization of the intraepiderm al cleft hi gh in the epidermiS 
ma y be related to the observatio n th at plas minogen acti vator 
levels see m to be high in more differenti ated cultured epiderm al 
cell s [15-171 . 
The res ults presented here, togeth er w ith the ea rlier observa tion 
Figure 3. Inh ibition of plas minogen-induced acantho lys is by anti-urokinase IgG. Explants of no rmal human skin were incubated for 48 h with human 
plas minogen (0.26 m g/ml) in the presence (A) or absence (B) of rabbit anti-hum an urokinase IgG (0.2 mg/ ml). Ex plants we re then processed for 
routine histo log ic exa mination using hem atoxylin and eos in stai ns and slides were photographed w ith a Z eiss microscope (250 x). Plasminogen- induced 
pemphig us fo li aceo us-like acantho lys is (B) was completel y prevented by the add itio n of anti-urokinase IgG (A). 
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[6] th at pemphi g us IgG enh ances plasminogen activa tor ill cul-
tured keratinocy tes g ive stron g support to a central role for pbs-
1l1lnogen activato r ill th e development of aca ntho lys is . 
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